Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Cannabis Science Inc    

CANNABIS SCIENCE INC
Mes dernières consult.
Most popular
Report
 SummaryNewsCompany 
Company
Cannabis Science, Inc. develops cannabis pharmaceutical products.The company works on phytocannabinoid science targeting critical illnesses and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.Cannabis Science was founded by... 
More about the company
Latest news on CANNABIS SCIENCE INC
01/19 CANNABIS SCIENCE : Announces an Overwhelming Response to its Groundbreaking Rese..
01/18 Cannabis Science Announces an Overwhelming Response to its Groundbreaking Res..
01/17 CANNABIS SCIENCE : Crown Baus Capital Acquires Military Grade CryptoGraphic Secu..
01/17 CROWN BAUS CAPITAL (OTC : CBCA) Acquires Military Grade CryptoGraphic Secure Onl..
01/12 CANNABIS SCIENCE : Announces its Construction Project Management Teams in Suppor..
01/10 Cannabis Science Announces its Construction Project Management (CPMT) Teams i..
01/10 CANNABIS SCIENCE : Actively Pursuing U.S. Federal Government Contracts and Is Pr..
01/10 CANNABIS SCIENCE : Actively Pursuing U.S. Federal Government Contracts and Is Pr..
01/09 Cannabis Science Actively Pursuing U.S. Federal Government Contracts and Is P..
01/09 CANNABIS SCIENCE : Prepares for the Grand Opening of Its First Two Pre ICO Pharm..
More news
Sector news : Bio Therapeutic Drugs
01/17 CELGENE : Conducts Deal Talks With Juno -- WSJ
01/16 CELGENE : in Talks to Buy Juno Therapeutics -- Update
01/16 CELGENE : in Talks to Buy Juno Therapeutics
01/12 Drugmakers see a pricing blueprint in an $850,000 gene therapy
01/12 SPARK'S PRICE FOR LUXTURNA BLINDNESS : Icer
More sector news : Bio Therapeutic Drugs
Managers
NameTitle
Raymond C. Dabney President, Chief Executive Officer & Director
Robert Kane Chief Operating Officer & Director
Benjamin C. K. Tam Chief Financial Officer, Secretary & Director
Richard Ogden Chief Scientific Officer
Allen A. Herman Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
CANNABIS SCIENCE INC0
GILEAD SCIENCES14.10%105 754
VERTEX PHARMACEUTICALS4.76%39 951
REGENERON PHARMACEUTICALS-0.50%39 917
GENMAB10.50%11 762
EXELIXIS, INC.-9.57%8 284